David Norman, MD
Professor Emeritus
Radiology
School of Medicine

Following military service in Vietnam and Denver, Dr. Norman completed a Neuroradiology fellowship at UCSF. In 2006, after a long and prolific career, Dr. Norman retired from the Department of Radiology.

Dr. Norman was among the first to highlight the use of MR imaging in the spinal cord, and his many subsequent contributions have contributed to current understanding of many disease states. Dr. Norman was integral to the development of new interventional angiographic techniques, and when MR imaging emerged, he made a name for UCSF in the new technology. In 1981 he wrote an article on dynamic computed tomography, which is published in the American Journal of Roentgenology. He was one of the first to detail the basis of the perfusion techniques that are used today. In that article, he wrote, “The concept of corrected mean transit time (MTT) applied to rapid sequence scans after intravenous bolus injection of contrast material provides quantitative data on hemispheric flow.” After 25 years, MTT maps are used everyday in the reading room.

Expertise: Neuroradiology

Specialty: MR imaging

Professional Interests: Development of new interventional angiopgraphic techniques, MR and CT

Education and Training:

• Medical School: Ursinus College of Pennsylvania Medical School, Collegeville
• Internship: Hospital of the University of Pennsylvania, Philadelphia
• Residency: Columbia University Medical Center, New York - Radiology
• Fellowship: University of California, San Francisco - Neuroradiology
• California State Medical License (1970-present)
• Ohio State Medical License (1998, inactive)
• New York State Medical License (1999, inactive)
• National Medical Boards (1968-Present)
• Radiology Certificate (1972)
• Neuroradiology Certificate of Added Qualification (1996)

• Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
  Neurology 2002 Du AT, Schuff N, Laakso MP, Zhu XP, Jagust WJ, Yaffe K, Kramer JH, Miller BL, Reed BR, Norman D, Chui HC, Weiner MW
• Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes.
  Alzheimer disease and associated disorders 2002 Hsu YY, Schuff N, Amend DL, Du AT, Norman D, Chui HC, Jagust WJ, Weiner MW
• Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.
  Neurology 2002 Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW
• MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.
  Neurology 2001 Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, Norman D, Mack WJ, Willis L, Chui HC
• Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease.
  Journal of neurology, neurosurgery, and psychiatry 2001 Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW
• Temporal lobe epilepsy: qualitative reading of 1H MR spectroscopic images for presurgical evaluation.
  Radiology 2001 Capizzano AA, Vermathen P, Laxer KD, Ende GR, Norman D, Rowley H, Matson GB, Maudsley AA, Segal MR, Weiner MW
• Cortical metabolite alterations in abstinent cocaine and cocaine/alcohol-dependent subjects: proton magnetic resonance spectroscopic imaging.
  Addiction biology 1999 Meyerhoff DJ, Bloomer C, Schuff N, Ezekiel F, Norman D, Clark W, Weiner MW, Fein G
• Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain.
  Radiology 1998 Schuff N, Amend DL, Meyerhoff DJ, Tanabe JL, Norman D, Fein G, Weiner MW
• Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study.
  Neurology 1997 Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW
• 1H MRSI of normal appearing white matter in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 1997 Rooney WD, Goodkin DE, Schuff N, Meyerhoff DJ, Norman D, Weiner MW
• Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.
  Radiology 1996 MacKay S, Ezekiel F, Di Sclafani V, Meyerhoff DJ, Gerson J, Norman D, Fein G, Weiner MW
• Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
  Archives of neurology 1996 MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW
• 1H and 31P magnetic resonance spectroscopic imaging of white matter signal hyperintensity areas in elderly subjects.
  Neuroradiology 1995 Constans JM, Meyerhoff DJ, Norman D, Fein G, Weiner MW
• Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
  Annals of neurology 1994 Meyerhoff DJ, MacKay S, Constans JM, Norman D, Van Dyke C, Fein G, Weiner MW